Ignite Creation Date:
2024-05-06 @ 12:53 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03870386
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2019-03-09
Brief Title:
EUS Biliary Drainage vs ERCP
Sponsor:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Organization:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Study Overview
Official Title:
EUS-guided Biliary Drainage of First Intent With the Lumen Apposing Metal Stent vs ERCP in the Management of Malignant Distal Biliary Obstruction a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endoscopic ultrasound guided biliary drainage EUS-BD is an evolving field that has grown in popularity in the management of malignant biliary obstruction Although Endoscopic retrograde cholangio-pancreatography ERCP with stent insertion has been the mainstay therapy throughout several decades the transpapillary approach through tumor tissue is associated with significant risk for adverse events such as post-ERCP pancreatitis and stent dysfunction from tumor tissue overgrowth and ingrowth EUS-BD through the creation of a choledochoduodenostomy with a stent has the potential advantage of avoiding the papilla and its associated complications while potentially improving stent patency with lower risks for tumor tissue ingrowth andor overgrowth
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None